ROBO vs XBI
ROBO Global Robotics and Automation Index ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.95% for ROBO.
- • ROBO pays a higher dividend yield (0.39%).
Side-by-side metrics
| Metric | ROBO | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.95% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.39% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $1.89B | $10.92B |
YTD return | 5.61% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.79 | 1.01 |
P/E ratio | 29.20 | — |
Last price | $74.56 | $156.41 |
Inception | — | — |
Issuer | ROBO Global | State Street |
ROBO top holdings
| ISRG | Intuitive Surgical Inc | 2.20% |
| PTC | PTC Inc | 1.85% |
| ROK | Rockwell Automation Inc | 1.79% |
| 6954.T | Fanuc Corp | 1.78% |
| NOVT | Novanta Inc | 1.76% |
| EMR | Emerson Electric Co | 1.67% |
| 2317.TW | Hon Hai Precision Industry Co Ltd | 1.61% |
| ILMN | Illumina Inc | 1.60% |
| HEXA-B.ST | Hexagon AB Class B | 1.59% |
| IPGP | IPG Photonics Corp | 1.58% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About ROBO
ROBO (ROBO Global Robotics and Automation Index ETF) is Robotics and automation companies worldwide. Managed by ROBO Global, the fund carries $1.9B in assets under management, an expense ratio of 0.95%, a dividend yield of 0.39%. Its largest holding is Intuitive Surgical Inc (ISRG), which represents 2.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 3.6%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.